GAMMA Investing’s Invesco Pharmaceuticals ETF PJP Stock Holding History

GAMMA Investing’s Portfolio PJP Stock Details PJP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$29.7K	Hold	241	–	–	﹤0.01%	2702
2026 Q2	$28.5K	Hold	241	–	–	﹤0.01%	2649
2026 Q1	$25K	Sell	241 -187	-44%	-$19.8K	﹤0.01%	2608
2025 Q4	$44.7K	Hold	428	–	–	﹤0.01%	2134
2025 Q3	$39.6K	Hold	428	–	–	﹤0.01%	2146
2025 Q2	$34.2K	Hold	428	–	–	﹤0.01%	2162
2025 Q1	$37.1K	Sell	428 -63	-13%	-$5.37K	﹤0.01%	2004
2024 Q4	$40.6K	Hold	491	–	–	﹤0.01%	1819
2024 Q3	$42.7K	Hold	491	–	–	﹤0.01%	1604
2024 Q2	$40.4K	Buy	+491	New	+$39K	0.01%	1349

Other funds holding PJP

GWM

Gilpin Wealth Management Denver, Colorado $148M AUM 25.13% 1-Year Est. Return

SIS

Sound Income Strategies Ft Lauderdale, Florida $2.24B AUM 8.38% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

AAG

Armstrong Advisory Group Needham, Massachusetts $1.66B AUM 13.15% 1-Year Est. Return

BTC

Bank & Trust Company Litchfield, Illinois $159M AUM 30.15% 1-Year Est. Return

GAMMA Investing's PJP Position: Q3 2026 in Review

GAMMA Investing held its Invesco Pharmaceuticals ETF (PJP) position steady in Q3 2026 at 241 shares worth $29.7K. The position accounts for ﹤0.01% of the portfolio, ranked #2702.

GAMMA Investing first reported a position in PJP in Q2 2024 and has held it in 10 quarters since. The position peaked at $44.7K in Q4 2025. 6 funds tracked by Wall St. Rank hold PJP as of Q3 2026.

GAMMA Investing held 241 shares of Invesco Pharmaceuticals ETF worth $29.7K as of Q3 2026.
GAMMA Investing left its Invesco Pharmaceuticals ETF share count unchanged in Q3 2026.
Invesco Pharmaceuticals ETF made up ﹤0.01% of GAMMA Investing's portfolio in Q3 2026, its #2702 holding.
GAMMA Investing first reported a position in Invesco Pharmaceuticals ETF in Q2 2024 and has held it in 10 quarters since.
GAMMA Investing's Invesco Pharmaceuticals ETF position peaked at $44.7K in Q4 2025.
6 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.